Advancing access, equity, and action in India and around the world
The Udaipur Type 1 Diabetes Summit gathered international leaders to develop a collaborative roadmap for strengthening T1D care across India.
“We are our own solution:” A T1D parent’s reflection on progress
Moira McCarthy reflects on the transformative impact of automated insulin delivery systems, and how the T1D community made it possible.
The power of play: T1D toys and games
Barbie is the latest in a long line of toys and games that increase type 1 diabetes (T1D) visibility and awareness.
Team Charlie’s Checkers: Walking in honor, now in memory
To know Charlie was to love him. His legacy lives on in every step his team takes at the Breakthrough T1D Walk.
170 Delegates make their mark on Capitol Hill at Breakthrough T1D 2025 Children’s Congress
170 Delegates with type 1 diabetes traveled to Washington, D.C. for the Breakthrough T1D 2025 Children's Congress.
Who is at risk for type 1 diabetes?
Although its exact causes are unknown, researchers have uncovered type 1 diabetes risk factors that increase a person's likelihood of developing the condition.
The first Barbie doll with type 1 diabetes
Breakthrough T1D and Mattel created the first Barbie doll with type 1 diabetes, creating T1D community visibility through play.
Everything you need to know about ADA 2025
Check out Breakthrough T1D's ADA 2025 coverage of cutting-edge T1D updates in cures, improving lives, and clinical adoption.
Can continuous glucose monitors benefit people without type 1 diabetes?
Continuous glucose monitors have been transformative for daily type 1 diabetes management. Can they benefit people without diabetes?
ADA 2025 Recap: Medical Affairs
Medical Affairs (+Research and Advocacy) Breakthrough T1D’s Medical Affairs program is bridging the gap between access to and adoption of therapies, treatments, drugs, and devices for T1D. To accomplish this goal, the Medical Affairs team is working on healthcare provider (HCP) education, development of clinical care guidelines, and clinical trial education and awareness. Breakthrough T1D’s […]
